Back
Direxion Daily Gold Miners Bull 2X ETF Vs. ProShares Ultra Nasdaq Biotechnology Industry Stock Comparison
Buy
53
NUGT
Direxion Daily Gold Miners Bull 2X ETF
Last Price:
41.84
Seasonality Move:
0.99%
Buy
60
BIB
ProShares Ultra Nasdaq Biotechnology
Last Price:
54.60
Seasonality Move:
12.47%
Buy
53
Direxion Daily Gold Miners Bull 2X ETF (NUGT)
is a Buy
Is Direxion Daily Gold Miners Bull 2X ETF a Buy, Sell or Hold?
- The current Direxion Daily Gold Miners Bull 2X ETF [NUGT] share price is $41.79. The Score for NUGT is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
- NUGT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
60
ProShares Ultra Nasdaq Biotechnology (BIB)
is a Buy
Is ProShares Ultra Nasdaq Biotechnology a Buy, Sell or Hold?
- The current ProShares Ultra Nasdaq Biotechnology [BIB] share price is $54.47. The Score for BIB is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
- BIB is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
NUGT Stock Price Chart
What is Direxion Daily Gold Miners Bull 2X ETF's stock price today?
-
The Direxion Daily Gold Miners Bull 2X ETF share price today is $41.79
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NUGT is experiencing selling pressure, which indicates risk of future bearish movement.
BIB Stock Price Chart
What is ProShares Ultra Nasdaq Biotechnology's stock price today?
-
The ProShares Ultra Nasdaq Biotechnology share price today is $54.47
The current trend is moderately bullish and BIB is experiencing selling pressure, which indicates risk of future bearish movement.
NUGT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.4 | Buy |
| Relative Strength Index (14 RSI): | 62.69 | Buy |
| Chaikin Money Flow: | -2223076 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (37.45 - 40.45) | Buy |
| Bollinger Bands (100): | (27.04 - 37.44) | Buy |
BIB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.45 | Buy |
| Relative Strength Index (14 RSI): | 54.89 | Buy |
| Chaikin Money Flow: | -12036 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (49.4 - 54.52) | Buy |
| Bollinger Bands (100): | (52.83 - 59.25) | Sell |
NUGT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 39.48 | Buy |
| 20-day SMA: | 38.84 | Buy |
| 50-day SMA: | 35.42 | Buy |
| 200-day SMA: | 31.51 | Buy |
| 8-day EMA: | 40.1 | Buy |
| 20-day EMA: | 38.85 | Buy |
| 50-day EMA: | 36.05 | Buy |
| 200-day EMA: | 33.36 | Buy |
BIB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 54.73 | Sell |
| 20-day SMA: | 51.64 | Buy |
| 50-day SMA: | 54.38 | Buy |
| 200-day SMA: | 52.06 | Buy |
| 8-day EMA: | 54.29 | Buy |
| 20-day EMA: | 53.25 | Buy |
| 50-day EMA: | 53.84 | Buy |
| 200-day EMA: | 53.61 | Buy |
Direxion Daily Gold Miners Bull 2X ETF Earnings Growth & NUGT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
ProShares Ultra Nasdaq Biotechnology Earnings Growth & BIB Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Direxion Daily Gold Miners Bull 2X ETF Technical Analysis
| Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
ProShares Ultra Nasdaq Biotechnology Technical Analysis
| Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||